Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashDepreciation & Amortization (CF)Free Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther financing activitiesShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Neurogene (NGNE) Non-cash Items (2018 - 2020)

Neurogene (NGNE) has disclosed Non-cash Items for 3 consecutive years, with $1.8 million as the latest value for Q3 2020.

  • For the quarter ending Q3 2020, Non-cash Items changed N/A year-over-year to $1.8 million, compared with a TTM value of $1.8 million through Sep 2020, changed N/A, and an annual FY2019 reading of $45.0 million, up 3646.63% over the prior year.
  • Non-cash Items was $1.8 million for Q3 2020 at Neurogene, up from $983334.0 in the prior quarter.
  • Across five years, Non-cash Items topped out at $45.0 million in Q4 2019 and bottomed at $983334.0 in Q2 2020.
  • Average Non-cash Items over 3 years is $6.1 million, with a median of $1.2 million recorded in 2018.
  • The sharpest move saw Non-cash Items soared 3646.63% in 2019, then dropped 3.77% in 2020.
  • Year by year, Non-cash Items stood at $1.2 million in 2018, then skyrocketed by 3646.63% to $45.0 million in 2019, then tumbled by 95.91% to $1.8 million in 2020.
  • Business Quant data shows Non-cash Items for NGNE at $1.8 million in Q3 2020, $983334.0 in Q2 2020, and $1.0 million in Q1 2020.